Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-08-06

Clinical Trial Update: Reduction of Anticholinergic Medications Among Persons With Schizophrenia or Other Psychiatric Disorders [NA]

View source ↗

Summary

A clinical trial is investigating reduction of anticholinergic medications among persons with schizophrenia or other psychiatric disorders. The study is current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Pittsburgh | Conditions: Schizophenia Disorder, Schizoaffective Disorder | NA | Status: RECRUITING